Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/7/2025

Diagnosis and Management of Diabetes Mellitus

Diagnostic Criteria

  • The American Diabetes Association recommends diagnosing diabetes mellitus when any of the following criteria are met on two separate occasions: Fasting Plasma Glucose (FPG) ≥ 126 mg/dL, 2-hour Plasma Glucose ≥ 200 mg/dL during OGTT, or Random Plasma Glucose ≥ 200 mg/dL with symptoms of hyperglycemia, and Hemoglobin A1C ≥ 6.5% using a method certified by the National Glycohemoglobin Standardization Program (NGSP) and standardized to the Diabetes Control and Complications Trial (DCCT) assay, with a strength of evidence based on expert consensus and clinical trials 1, 2, 3, 4, 5
  • Diagnosis requires either two abnormal results from the same test on different days, or abnormal results from two different tests obtained at the same time, unless unequivocal hyperglycemia is present, with a moderate level of evidence from observational studies 3, 4, 5, 1, 2, 6
  • Classic symptoms with a single random glucose ≥ 200 mg/dL is diagnostic and doesn't require confirmation, with a high level of evidence from clinical guidelines 1, 2, 3, 4

Prediabetes Diagnosis

  • The American Diabetes Association defines prediabetes as having an A1C of 5.7-6.4%, Fasting Plasma Glucose (FPG) of 100-125 mg/dL, or 2-hour Plasma Glucose of 140-199 mg/dL during OGTT, with a moderate level of evidence from observational studies 6, 4, 7
  • The following table summarizes the diagnostic criteria for diabetes and prediabetes:
Test Diagnostic Criteria Prediabetes Criteria
A1C ≥ 6.5% 5.7-6.4%
FPG ≥ 126 mg/dL 100-125 mg/dL
2-h PG during OGTT ≥ 200 mg/dL 140-199 mg/dL
Random Plasma Glucose ≥ 200 mg/dL with symptoms - [1, 2, 3, 4, 5]

Testing Recommendations

  • The American Diabetes Association recommends testing for diabetes in all adults who are overweight (BMI ≥ 25 kg/m²) with additional risk factors, and in those without risk factors, testing should begin at age 45 years, with a high level of evidence from clinical guidelines 6, 5
  • If results are normal, repeat testing at minimum 3-year intervals, and in those identified with prediabetes, assess and treat other cardiovascular risk factors, with a low level of evidence from expert opinion 6, 5

Potential Pitfalls

  • A1C testing should be avoided for diagnosis in conditions where the relationship between A1C and glycemia is altered, such as hemoglobinopathies, pregnancy, glucose-6-phosphate dehydrogenase deficiency, HIV infection, hemodialysis, recent blood loss, transfusion, or erythropoietin therapy, or iron-deficient anemia, with a moderate level of evidence from observational studies 4, 1, 5
  • If two different tests are available and results are discordant, the test whose result is above the diagnostic cut point should be repeated, and consider the possibility of A1C assay interference if marked discrepancies exist between A1C and glucose measurements, with a low level of evidence from expert opinion and case reports 8, 7, 1, 2, 6
  • Failure to confirm abnormal results with repeat testing unless unequivocal hyperglycemia is present, can lead to incorrect diagnosis, with a low level of evidence from case reports and expert opinion 3, 5
  • Using A1C for diagnosis in contraindicated conditions, such as hemoglobinopathies or pregnancy, can lead to incorrect diagnosis, with a moderate level of evidence from observational studies 1, 5
  • Ignoring preanalytical variables, such as the need for prompt glucose sample processing to prevent falsely low results due to glycolysis, can affect diagnosis, with a low level of evidence from expert opinion 4